Tag Archives: hereditary cancer

New Study: Genetic testing for inherited mutations may be helpful for all people with advanced or metastatic cancer

In a study of nearly 12,000 cancer patients with a variety of cancers, eight percent of participants with metastatic cancer had an inherited mutation in a cancer gene that qualified them for a targeted treatment or for participation in a clinical trial. The majority of people with metastatic cancer were unaware that they had an inherited mutation, and had not receive gene-directed treatment to which their tumor may have responded. Of the study participants, 17% tested positive for an inherited mutation in a gene linked to cancer and a potential treatment based on genetic test results existed for 10% of patients in this study. The most commonly found mutation were one of the two BRCA genes. The study authors suggest that genetic testing for inherited mutations may be warranted for all patients with advanced or metastatic cancer. To learn more and read further into this study, please click here: https://www.facingourrisk.org/XRAY/genetic-testing-needed-for-all-with-metastatic-cancer?utm_source=Pardot&utm_medium=email&utm_campaign=XRAY_Digest_Fall_2021

 

Webinar: Hereditary Prostate Cancer Treatment

This expert-led webinar presented by Heather Cheng, MD, PhD, discusses the importance of identifying hereditary cancer risk mutations for prostate cancer. Dr. Cheng discusses prostate cancer treatment and trials, as well as, screening trials for men with hereditary prostate cancer.

About The Speaker

Heather Cheng, MD, PhD

Dr. Heather Cheng, MD, PhD, is an Associate Professor in Medicine (Oncology Division) at the University of Washington, an Associate Member of the Division of Clinical Research at the Fred Hutch Cancer Research Center and is Director of the Prostate Cancer Genetics Clinic at the Seattle Cancer Care Alliance. As a medical oncologist she designs and conducts therapeutic clinical trials, particularly for men whose cancers have mutations in genes related to DNA repair, such as BRCA2, BRCA1.

Please find the link to the webinar-on-demand here.